Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The aquaporin 10 pseudogene (ENSG00000278694) is a non-coding genetic locus that has lost its functional protein-coding ability due to mutations such as frame-shifts, premature stop codons, and aberrant splice sites. Aquaporin 10 (AQP10) itself is a member of the aquaglyceroporin family, integral membrane proteins that facilitate the transport of water and small solutes like glycerol[1]. In humans and various mammals (such as mice, cattle, sheep, and goats), the aquaporin 10 pseudogene does not produce a functional protein, and thus lacks the physiological roles typical of aquaporins[1][3]. There is no evidence it is involved in signaling, transport, or as a molecular target in disease or therapeutic intervention. Its presence is typically the result of evolutionary gene duplication and subsequent loss of functional constraint[1][3].
Not applicable (no mechanism of action, as there is no therapeutic or pharmacological targeting)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquaporin 10 pseudogene (None commonly in use (AQP10P is sometimes seen in database contexts, but not standardized)).